Uma doença geralmente grave que afeta vários sistemas do corpo, causada por um problema no metabolismo do cobre. Caracteriza-se pela degeneração progressiva das células nervosas, por alterações importantes nos tecidos que dão suporte ao organismo (como pele, ossos e vasos sanguíneos), além de cabelos ralos, com aspecto incomum e uma textura que lembra aço.
Introdução
O que você precisa saber de cara
Uma doença geralmente grave que afeta vários sistemas do corpo, causada por um problema no metabolismo do cobre. Caracteriza-se pela degeneração progressiva das células nervosas, por alterações importantes nos tecidos que dão suporte ao organismo (como pele, ossos e vasos sanguíneos), além de cabelos ralos, com aspecto incomum e uma textura que lembra aço.
Escala de raridade
<1/50kMuito rara
1/20kRara
1/10kPouco freq.
1/5kIncomum
1/2k
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 29 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 73 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
1 gene identificado com associação a esta condição. Padrão de herança: X-linked recessive.
ATP-driven copper (Cu(+)) ion pump that plays an important role in intracellular copper ion homeostasis (PubMed:10419525, PubMed:11092760, PubMed:28389643). Within a catalytic cycle, acquires Cu(+) ion from donor protein on the cytoplasmic side of the membrane and delivers it to acceptor protein on the lumenal side. The transfer of Cu(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation that shifts the pump conformation from inward-facing to
Golgi apparatus, trans-Golgi network membraneCell membraneMelanosome membraneEarly endosome membraneCell projection, axonCell projection, dendritePostsynaptic densityCytoplasm, cytosolEndoplasmic reticulum
Menkes disease
An X-linked recessive disorder of copper metabolism characterized by generalized copper deficiency. MNKD results in progressive neurodegeneration and connective-tissue disturbances: focal cerebral and cerebellar degeneration, early growth retardation, peculiar hair, hypopigmentation, cutis laxa, vascular complications and death in early childhood. The clinical features result from the dysfunction of several copper-dependent enzymes. A mild form of the disease has been described, in which cerebellar ataxia and moderate developmental delay predominate.
Medicamentos aprovados (FDA)
1 medicamento encontrado nos registros da FDA americana.
Variantes genéticas (ClinVar)
604 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 2 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
3 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Doença Menkes
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
9 ensaios clínicos encontrados, 3 ativos.
Publicações mais relevantes
Zycubo (copper histidinate), the first treatment for pediatric Menkes disease.
Copper histidinate (marketed as ZYCUVO®, formerly known as CUTX-101) is a copper replacement product indicated for the treatment of Menkes disease in pediatric patients. The chemical name is copper, (L-histidinato-κN,κN3,κO)(L-histidinato-κN,κO)-, (SP-5–14-C)- or copper bis((2S)-2-amino-3-(1H-imidazol-5-yl)propanoate). Copper histidinate has a molecular formula of C12H16CuN6O4 and a molecular weight of 371.84 g/mol. The molecule consists of a central copper (II) ion coordinated by two L-histidine ligands through nitrogen and oxygen donor atoms, forming a stable chelated complex that facilitates systemic copper delivery following subcutaneous administration. Copper histidinate is fully soluble in water, forming a blue solution. Reconstituted solutions must be used within 4 hours at room temperature (20°C to 25°C) or within 24 hours if refrigerated (2°C to 8°C). [Image: see text]
Research Progress on Copper Metabolism, Cuprotosis, and Their Regulatory Mechanism in Tumor Diagnosis and Treatment.
A co-factor of multiple metalloenzymes that promote normal physiological functions, such as the immune system, neurological system, human hematological function, bone health, and antioxidant action, copper is one of the most important trace metals in the human body. The copper content in the human body maintains a relatively constant level; too much copper can cause Wilson's disease, and too little can cause Menkes disease. Copper is involved in the physiological functions of many body systems and has a very complex transport system with many transporters. In order to offer fresh concepts and a theoretical foundation for cancer treatment, this article will go into great detail about the distinct metabolic pathways of copper and the function of cell death, particularly the function of copper-controlled cell death, especially cuproptosis, in cancer detection and treatment. Cuproptosis, a copper-dependent cell death distinct from necrosis, apoptosis, and ferroptosis, is triggered by excessive intracellular copper binding to lipoylated tricarboxylic acid (TCA) cycle proteins, leading to abnormal protein aggregation and loss of iron-sulfur clusters in respiratory chain complexes. Future research may focus on optimizing the specificity of copper metabolism-related biomarkers (eg, CTR1, SOD1) for early tumor screening, developing targeted copper ionophores/chelators with low systemic toxicity, and exploring the crosstalk between copper metabolism and tumor immunity to establish multi-dimensional diagnosis and treatment strategies.
Copper Homeostasis and Cuproptosis in Neurological Disorders.
Neurological disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD) pose a serious global public health threat, with complex etiologies involving genetic, environmental, and metabolic factors. Current data indicate that the prevalence of these disorders is rapidly increasing with the aging population, resulting in a growing economic and healthcare burden worldwide. In recent years, the imbalance of copper homeostasis has been increasingly implicated in the pathogenesis of neurological diseases. Copper overload can aggravate neuronal injury by inducing oxidative stress (OS), mitochondrial dysfunction, and protein misfolding, while copper deficiency disrupts the function of copper-dependent enzymes and leads to metabolic abnormalities. The mechanism of cuproptosis, proposed in 2022, describes a novel form of programmed cell death characterized by lipoylated protein aggregation and the loss of Fe-S cluster proteins, offering new insights into copper-related diseases. Multiple studies have demonstrated the crucial role of copper homeostasis and cuproptosis in the onset, progression, and treatment of neurological diseases. This narrative review summarizes the molecular mechanisms involved in copper homeostasis regulation and, on that basis, discusses the role of copper metabolism abnormalities in AD, PD, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Wilson's disease (WD), Menkes disease (MD), and stroke. Additionally, we highlight the mechanisms of existing copper-regulating drugs and their therapeutic potential in neurological disorders, while pointing out the limitations of current drug development. Copper homeostasis imbalance plays a critical regulatory role in neurological disorders.Cuproptosis is a unique form of copper-mediated cell death that plays a key role in neuronal injury.Many key questions regarding the differences in copper homeostasis and cuproptosis mechanisms among various neurological disorders remain unresolved.The interplay between copper and other metal ions (such as iron and zinc) in maintaining homeostasis may have important implications in neurological disorders.
Patient Burden in the Treatment of Wilson Disease in the United States: An Analysis of Real-World Health Insurance Claims Data from the Komodo database.
Wilson disease (WD) is a rare inherited disorder that causes copper accumulation and can be fatal if untreated. This study used real-world data from the US Komodo Health claims database to describe healthcare resource utilization (HCRU) and evaluate direct economic costs among patients with WD. This retrospective observational study identified patients with WD using ICD-9/10 codes (excluding Menkes disease) between 2016 and 2019, with data spanning 2012-2020. Sociodemographic characteristics, HCRU, and costs were analyzed using SPSS v23, SAS v9.4, and R v3.6.0. The study was approved by Pearl Pathways IRB (#20-KANT-224). A total of 2115 patients with prevalent WD, including 360 ever-treated (with reimbursable WD prescriptions), were identified. During the 2-year follow-up, about 25% were hospitalized, with a mean stay of 9 days, and most visited the ER three times annually. Hepatic patients with WD were more likely to undergo liver biopsy or transplant but had fewer home health visits and less use of assistive mobility devices. Annual liver transplant costs averaged $9094.72 ± 8110.23 per prevalent WD patient and $10,147.98 ± 7030.83 per ever-treated patient. Mean annual costs per prevalent versus ever-treated patients with WD were inpatient ($716.52 ± 2675.06 vs. $252.75 ± 333.39), pharmacy ($270.35 ± 1348.79 vs. $1284.51 ± 2994.85), and outpatient ($73.93 ± 156.89 vs. $60.82 ± 62.17), respectively. Pharmacy costs for adherent patients averaged $157,505.28 for any medication, $252,617.11 for D-penicillamine, $189,328.52 for trientine, and $1574.91 for zinc. Among ever-treated patients with WD, respective costs were lower at $85,117.60, $123,190.73, $100,017.20, and $820.35. Estimated annual HCRU and treatment costs for patients with WD were lower than previously reported. These findings provide updated real-world insights into the economic burden of WD and highlight the cost implications of medication adherence in managing this rare disorder in the USA.
Whole genome sequencing from dried blood spots for newborn screening of Menkes disease and 36 other actionable inherited neurometabolic disorders.
Tandem mass spectrometry is currently used by the Ohio Department of Health to screen newborn infants for 36 medically actionable inborn errors of metabolism. As a complementary test for infants with abnormal biochemical screens, whole genome sequencing (WGS) theoretically could reduce false-positive results, facilitate timely case resolution and, in some instances, indicate a more specific diagnosis than obtained initially. Menkes disease is a X-linked recessive disorder of human copper metabolism with a predicted minimum birth prevalence of 1 in 34,810 live male births. Recent progress in treatment options for Menkes heighten the importance of newborn screening (NBS) to identify this illness within the window of therapeutic opportunity, the first 4 to 6 weeks of life. We developed a DNA extraction protocol from dried blood spots that yielded high quality DNA for whole genome sequencing and studied 24 subjects with known ATP7A variants. Analysis was confined to genes (n = 55) for neurometabolic conditions currently screened for in Ohio (n = 36) plus ATP7A (Menkes disease). WGS detected all ATP7A variants including 7 missense, 5 splice site, 4 copy number variants, 4 nonsense, 3 indels, and 1 missense/splice site. WGS also detected 5 heterozygous pathogenic variants in 5 genes that encode conditions for which Ohio screens. Our results confirm the feasibility and reliability of this approach for early Menkes disease detection and to complement tandem mass spectroscopy for detection of other actionable inherited disorders.
Publicações recentes
Menkes Disease: Another Example of Progress in the Development of Pharmaceuticals for Rare Childhood Diseases, But Much Still Remains to Be Done.
🥇 Revisão sistemáticaResearch Progress on Copper Metabolism, Cuprotosis, and Their Regulatory Mechanism in Tumor Diagnosis and Treatment.
Zycubo (copper histidinate), the first treatment for pediatric Menkes disease.
Copper Homeostasis and Cuproptosis in Neurological Disorders.
🥈 ObservacionalPatient Burden in the Treatment of Wilson Disease in the United States: An Analysis of Real-World Health Insurance Claims Data from the Komodo database.
📚 EuropePMC480 artigos no totalmostrando 196
Menkes Disease: Another Example of Progress in the Development of Pharmaceuticals for Rare Childhood Diseases, But Much Still Remains to Be Done.
Clinical therapeuticsResearch Progress on Copper Metabolism, Cuprotosis, and Their Regulatory Mechanism in Tumor Diagnosis and Treatment.
Cancer management and researchZycubo (copper histidinate), the first treatment for pediatric Menkes disease.
Trends in pharmacological sciencesCopper Homeostasis and Cuproptosis in Neurological Disorders.
Drug design, development and therapyPatient Burden in the Treatment of Wilson Disease in the United States: An Analysis of Real-World Health Insurance Claims Data from the Komodo database.
Advances in therapyConcerns regarding the safety and efficacy of ES-Cu-Captisol for Menkes disease. Reply.
The Journal of clinical investigationConcerns regarding the safety and efficacy of ES-Cu-Captisol for Menkes disease.
The Journal of clinical investigationWhole genome sequencing from dried blood spots for newborn screening of Menkes disease and 36 other actionable inherited neurometabolic disorders.
Molecular genetics and metabolismDistinct signaling mechanisms and proteome phenotypes are elicited by compartment-specific genetic defects of copper homeostasis.
bioRxiv : the preprint server for biologyNON-REDUNDANT ROLES OF COPPER TRANSPORTERS ATP7A AND ATP7B IN NORADRENERGIC SIGNALING.
bioRxiv : the preprint server for biologyDeciphering Copper Homeostasis and Cuproptosis: Biological Mechanisms, Disease Connections, and Cutting-Edge Copper-Based Nanomedicine.
Molecular pharmaceuticsCRISPR prime editing as a promising therapeutic avenue for Menkes disease: the next step in correcting ATP7A mutations.
Annals of medicine and surgery (2012)Role of cuproptosis in digestive system tumors (Review).
International journal of molecular medicineRetropseudogene insertion generated through retrotransposition in the ATP7A gene results in premature stop codons and a case of Menkes disease.
Frontiers in neurologyEarly-onset urinary calculi in Menkes disease: A rare presentation in a 5-month-old infant.
Pediatrics international : official journal of the Japan Pediatric SocietyElesclomol-Mediated Alterations of Liver Metabolism in the Context of Mouse Mblac1 Disruption.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International ConferenceCopper in Human Health and Disease: Insights from Inherited Disorders.
Physiology (Bethesda, Md.)Copper homeostasis and cuproptosis: implications for neurodegenerative diseases.
Frontiers in aging neuroscienceNovel ATP7A Splice-Site Variant Causing Distal Motor Neuropathy and Occipital Horn Syndrome: Two Siblings and Literature Review.
GenesInterference-free SERS tags for copper ion sensing upon hypoxia by in situ hot-spot generation.
TalantaIntravenous AAV9-ATP7A plus subcutaneous copper histidinate optimizes outcomes in a lethal Menkes disease mouse model.
Science advancesElesclomol-copper therapy improves neurodevelopment in two children with Menkes disease.
The Journal of clinical investigationAlpha-synuclein null mutation exacerbates the phenotype of a model of Menkes disease in female mice.
Frontiers in neuroscienceAtp7a deficiency induces axonal and myelin developmental defects in zebrafish via ferroptosis.
Neurobiology of diseaseSevere Shock Caused by Rupture of Bladder Diverticulum in a Patient With Menkes Disease: A Case Report.
Clinical case reportsOvercoming barriers in Menkes disease: A standardized high quality and stable injectable copper histidinate.
Journal of pharmaceutical sciencesElesclomol rescues mitochondrial copper deficiency in disease models without triggering cuproptosis.
The Journal of pharmacology and experimental therapeuticsMenkes disease with unilateral lacrimal fistula.
Journal francais d'ophtalmologieIdentification of a Novel ATP7A Variant in a Chinese Boy With Developmental Delay and Epilepsy.
International journal of developmental neuroscience : the official journal of the International Society for Developmental NeuroscienceRestoration of Genetic Code in Macular Mouse Fibroblasts via APOBEC1-Mediated RNA Editing.
BiomoleculesCopper homeostasis and pregnancy complications: a comprehensive review.
Journal of assisted reproduction and geneticsTwo Cases of Menkes Disease With Similar Intracranial Arterial Tortuosity on Brain Magnetic Resonance Imaging.
CureusCopper homeostasis and neurodegenerative diseases.
Neural regeneration researchCase Report: A male newborn with occipital horn syndrome.
F1000ResearchCopper and Colorectal Cancer.
CancersNovel, likely pathogenic variant in ATP7A associated with Menkes disease diagnosed with ultrarapid genome sequencing.
BMJ case reports[Epilepsy and inborn errors of metabolism].
Revista de neurologiaMammalian copper homeostasis: physiological roles and molecular mechanisms.
Physiological reviewsFocus on cuproptosis: Exploring new mechanisms and therapeutic application prospects of cuproptosis regulation.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapieRole of copper in central nervous system physiology and pathology.
Neural regeneration researchPhenotypic and mutational spectrum of 17 Chinese patients with Menkes Disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology[Research progress on regulatory mechanism of renal copper homeostasis].
Sheng li xue bao : [Acta physiologica Sinica]Brain and the whole-body bone imaging appearances in Menkes disease: a case report and literature review.
BMC pediatricsUnraveling Copper Exchange in the Atox1-Cu(I)-Mnk1 Heterodimer: A Simulation Approach.
The journal of physical chemistry. BThe physiological and pathophysiological roles of copper in the nervous system.
The European journal of neuroscienceSynthesis and Biological Activities of Some Metal Complexes of Peptides: A Review.
Biotech (Basel (Switzerland))Mechanism of Cu entry into the brain: many unanswered questions.
Neural regeneration researchPreimplantation genetic testing for monogenic disorders (PGT-M) offers an alternative strategy to prevent children from being born with hereditary neurological diseases or metabolic diseases dominated by nervous system phenotypes: a retrospective study.
Journal of assisted reproduction and geneticsCuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy.
CancersDisorders of Copper Metabolism in Children-A Problem too Rarely Recognized.
MetabolitesCopper release by MOF-74(Cu): a novel pharmacological alternative to diseases with deficiency of a vital oligoelement.
RSC advancesUnfavorable switching of skewed X chromosome inactivation leads to Menkes disease in a female infant.
Scientific reportsDeep intronic variant causes aberrant splicing of ATP7A in a family with a variable occipital horn syndrome phenotype.
European journal of medical geneticsInsights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds.
Current neuropharmacology[Analysis of clinical characteristics and ATP7A gene variants in a Chinese pedigree affected with Menkes disease].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsMassive thrombosis in internal jugular phlebectasia in Menkes disease.
Pediatrics international : official journal of the Japan Pediatric SocietyThe Tao of Copper Metabolism: From Physiology to Pathology.
Current medicinal chemistryCurrent and Future of "Turn-On" Based Small-Molecule Copper Probes for Cuproptosis.
ChemistryOpenLAT1 (SLC7A5) catalyzes copper(histidinate) transport switching from antiport to uniport mechanism.
iScienceCopper-transporting ATPases throughout the animal evolution - From clinics to basal neuron-less animals.
GeneAn ESIPT solvatochromic fluorescent and colorimetric probe for sensitive and selective detection of copper ions in environmental samples and cell lines.
The AnalystGenetic etiology of progressive pediatric neurological disorders.
Pediatric researchBioactive copper(II) agents and their potential involvement in the treatment of copper deficiency-related orphan diseases.
Journal of inorganic biochemistryThe 100 top-cited articles in the field of Wilson's disease from 1990 to 2022: A bibliometric study.
HeliyonIntegrating reduced amino acid composition into PSSM for improving copper ion-binding protein prediction.
International journal of biological macromolecules[Clinical and genetic analysis of three children with Menkes disease due to variants of ATP7A gene].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsRegulatory roles of copper metabolism and cuproptosis in human cancers.
Frontiers in oncologyEthics in pre-ART genetics: a missed X-linked Menkes disease case.
Journal of assisted reproduction and geneticsMenkes disease complicated by concurrent ACY1 deficiency: A case report.
Frontiers in geneticsHealth-Related Quality of Life and Family Functioning of Primary Caregivers of Children with Menkes Disease.
Journal of clinical medicineFDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery.
Proceedings of the National Academy of Sciences of the United States of AmericaCopper homeostasis and the ubiquitin proteasome system.
Metallomics : integrated biometal scienceATP7A-related copper transport disorders: A systematic review and definition of the clinical subtypes.
Journal of inherited metabolic diseaseAtp7b-dependent choroid plexus dysfunction causes transient copper deficit and metabolic changes in the developing mouse brain.
PLoS geneticsEvaluation of hair structural abnormalities in children with different neurological diseases.
The Turkish journal of pediatricsFatal congenital copper transport defect caused by a homozygous likely pathogenic variant of SLC31A1.
Clinical geneticsHeterogeneous nuclear ribonucleoprotein hnRNPA2/B1 regulates the abundance of the copper-transporter ATP7A in an isoform-dependent manner.
Frontiers in molecular biosciencesMitochondrial copper in human genetic disorders.
Trends in endocrinology and metabolism: TEMDecreased Expression of the Slc31a1 Gene and Cytoplasmic Relocalization of Membrane CTR1 Protein in Renal Epithelial Cells: A Potent Protective Mechanism against Copper Nephrotoxicity in a Mouse Model of Menkes Disease.
International journal of molecular sciencesNewly identified disorder of copper metabolism caused by variants in CTR1, a high-affinity copper transporter.
Human molecular geneticsElesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery.
The Journal of biological chemistryAlmost misdiagnosed Menkes disease: A case report.
HeliyonOral Elesclomol Treatment Alleviates Copper Deficiency in Animal Models.
Frontiers in cell and developmental biologyIdentification of a Novel Deep Intronic Variant by Whole Genome Sequencing Combined With RNA Sequencing in a Chinese Patient With Menkes Disease.
Frontiers in geneticsCopper-histidine therapy in an infant with novel splice-site variant in the ATP7A gene of Menkes disease: the first experience in South East Asia and literature review.
BMJ case reportsCritical Points in the Methodology of Preparing Copper (II) Histidinate Injections and their Quality Assessment Applying Color Measurement.
Journal of pharmaceutical sciencesEarly clinical signs and treatment of Menkes disease.
Molecular genetics and metabolism reportsAbnormal Development of Neural Stem Cell Niche in the Dentate Gyrus of Menkes Disease.
International journal of stem cellsMenkes Disease: Clinical Presentation and Imaging Characteristics.
NeuropediatricsUsefulness of Trichoscopy over Hair Light Microscopy in Menkes Disease.
Skin appendage disordersHair microscopy: an easy adjunct to diagnosis of systemic diseases in children.
Applied microscopyTracking Labile Copper Fluctuation In Vivo/Ex Vivo: Design and Application of a Ratiometric Near-Infrared Fluorophore Derived from 4-Aminostyrene-Conjugated Boron Dipyrromethene.
Inorganic chemistrySeizures of unknown etiology associated with brittle hair: A diagnostic challenge.
JAAD case reportsPili Torti: A Feature of Numerous Congenital and Acquired Conditions.
Journal of clinical medicineTubular Dysfunction and Ruptured Ureter in a Child with Menkes Syndrome.
Case reports in pediatricsMenkes disease diagnosed by a novel ATP7A frameshift mutation in a patient with infantile spasms-a case report.
Translational pediatricsPharmacokinetics of CuGTSM, a Novel Drug Candidate, in a Mouse Model of Menkes Disease.
Pharmaceutical researchThe molecular and cellular basis of copper dysregulation and its relationship with human pathologies.
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyTherapeutic Use of Trace Elements in Dermatology.
Alternative therapies in health and medicineCopper nutrition and biochemistry and human (patho)physiology.
Advances in food and nutrition researchWhole-Exome Sequencing, Proteome Landscape, and Immune Cell Migration Patterns in a Clinical Context of Menkes Disease.
GenesNeuropathological findings in a 17-month-old boy with kinky hair due to Menkes disease.
Clinical neuropathologyGenetic causes of fractures and subdural hematomas: fact versus fiction.
Pediatric radiologyOccipital Horn Syndrome as a Result of Splice Site Mutations in ATP7A. No Activity of ATP7A Splice Variants Missing Exon 10 or Exon 15.
Frontiers in molecular neuroscienceATP7A-Regulated Enzyme Metalation and Trafficking in the Menkes Disease Puzzle.
BiomedicinesHair Abnormalities: Key to Suspecting Menkes Disease.
Actas dermo-sifiliograficasCopper Toxicity Associated With an ATP7A-Related Complex Phenotype.
Pediatric neurology[Pedigree study and analysis of ATP7A gene variants in three children with Menkes disease].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsAntioxidant vs. Prooxidant Properties of the Flavonoid, Kaempferol, in the Presence of Cu(II) Ions: A ROS-Scavenging Activity, Fenton Reaction and DNA Damage Study.
International journal of molecular sciencesCOMMD1, a multi-potent intracellular protein involved in copper homeostasis, protein trafficking, inflammation, and cancer.
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron disease.
Neurobiology of diseaseInborn Errors of Metabolism in a Tertiary Pediatric Intensive Care Unit.
Journal of pediatric intensive careCopper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications.
International journal of molecular sciencesEffect of homeostatic iron regulator protein gene mutation on Wilson's disease clinical manifestation: original data and literature review.
The International journal of neuroscienceInvestigation of Genetic Modifiers of Copper Toxicosis in Labrador Retrievers.
Life (Basel, Switzerland)ATP7A mutation with occipital horns and distal motor neuropathy: A continuum.
European journal of medical geneticsRepurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders.
Expert opinion on investigational drugsATP7A Clinical Genetics Resource - A comprehensive clinically annotated database and resource for genetic variants in ATP7A gene.
Computational and structural biotechnology journalLaparoscopic patch repair of a Morgagni hernia in Menkes disease.
Asian journal of endoscopic surgeryLC-ICP-MS method for the determination of "extractable copper" in serum.
Metallomics : integrated biometal scienceWilson's Disease: Diagnosis of Wilson's Disease in Ethiopian Young Sisters.
Case reports in medicineTargeted next generation sequencing for newborn screening of Menkes disease.
Molecular genetics and metabolism reports[Menkes disease, a diagnosis to consider in case of severe epilepsy with hyperlactacidemia: a case report].
Annales de biologie cliniqueCancer Pro-oxidant Therapy Through Copper Redox Cycling: Repurposing Disulfiram and Tetrathiomolybdate.
Current pharmaceutical designLow function of natural killer cells in treated classic Menkes disease.
The Turkish journal of pediatricsEstimated birth prevalence of Menkes disease and ATP7A-related disorders based on the Genome Aggregation Database (gnomAD).
Molecular genetics and metabolism reportsZinc Monotherapy as an Alternative Treatment Option for Decompensated Liver Disease due to Wilson Disease?
Case reports in hepatologyThe molecular mechanisms of copper metabolism and its roles in human diseases.
Pflugers Archiv : European journal of physiologyVisual Dermatology: Menkes Disease.
Journal of cutaneous medicine and surgeryAn Unusual Presentation of Menkes Disease Masquerading as a Leukodystrophy with Macrocephaly.
Journal of pediatric neurosciencesRare Genetic Diseases: Nature's Experiments on Human Development.
iScienceElesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice.
Science (New York, N.Y.)Neck masses due to internal jugular vein phlebectasia: Frequency in Menkes disease and literature review of 85 pediatric subjects.
American journal of medical genetics. Part AFunctional analyses of copper transporter genes in the human liver cell line HepG2.
Toxicology in vitro : an international journal published in association with BIBRA[Genetic analysis of a male infant with Menkes disease].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsReduced Neutrophil Extracellular Trap (NET) Formation During Systemic Inflammation in Mice With Menkes Disease and Wilson Disease: Copper Requirement for NET Release.
Frontiers in immunologyOsseous Metaplasia in a Bladder Diverticulum in a Patient with Mosaic Menkes Disease.
UrologyCopper and the brain noradrenergic system.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic ChemistryHomozygous Loss-of-Function Mutations in AP1B1, Encoding Beta-1 Subunit of Adaptor-Related Protein Complex 1, Cause MEDNIK-like Syndrome.
American journal of human geneticsReport of a novel ATP7A mutation causing distal motor neuropathy.
Neuromuscular disorders : NMDWormian Bones and Dilated Scalp Veins in an Infant With Epilepsy.
Journal of pediatric neurosciencesAnimal Models of Normal and Disturbed Iron and Copper Metabolism.
The Journal of nutritionAdipocyte-specific disruption of ATPase copper transporting α in mice accelerates lipoatrophy.
DiabetologiaA severe case of Menkes disease with repeated bone fracture during the neonatal period, followed by multiple arterial occlusion.
Brain & developmentMenkes disease complicated by concurrent Koolen-de Vries syndrome (17q21.31 deletion).
Molecular genetics & genomic medicineCopper Deficiency: Causes, Manifestations, and Treatment.
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral NutritionImaging findings of Menkes disease, a radiographic mimic of abusive trauma.
Radiology case reportsClassification and differential diagnosis of Wilson's disease.
Annals of translational medicineRatiometric two-photon microscopy reveals attomolar copper buffering in normal and Menkes mutant cells.
Proceedings of the National Academy of Sciences of the United States of AmericaLong surviving classical Menkes disease treated with weekly intravenous copper therapy.
Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)Síntesis y uso de histidinato de cobre en niños con enfermedad de Menkes en México.
Gaceta medica de MexicoFatal Exsanguination Following Rupture of an Iliac Artery Aneurysm in an Infant With Menkes Disease.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyATP7A mutations in 66 Japanese patients with Menkes disease and carrier detection: A gene analysis.
Pediatrics international : official journal of the Japan Pediatric SocietyBiological role of copper as an essential trace element in the human organism.
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnostiUrological Problems in Patients with Menkes Disease.
Journal of Korean medical scienceCopper complexes for biomedical applications: Structural insights, antioxidant activity and neuron compatibility.
Journal of inorganic biochemistryA systematic review and evidence-based guideline for diagnosis and treatment of Menkes disease.
Molecular genetics and metabolismNovel ATP7A gene mutation in a patient with Menkes disease.
The application of clinical geneticsEpilepsy and Neurodegeneration: Clues in the Hair and Blood Vessels!
The Journal of pediatricsCu2+ selective chelators relieve copper-induced oxidative stress in vivo.
Chemical sciencePredictable and precise template-free CRISPR editing of pathogenic variants.
NatureChelating principles in Menkes and Wilson diseases: Choosing the right compounds in the right combinations at the right time.
Journal of inorganic biochemistryATP7A and ATP7B copper transporters have distinct functions in the regulation of neuronal dopamine-β-hydroxylase.
The Journal of biological chemistryEmergent embolization of a ruptured splenic artery aneurysm complicating Menkes disease.
Radiology case reportsDisulfiram enhanced delivery of orally administered copper into the central nervous system in Menkes disease mouse model.
Journal of inherited metabolic diseaseMenkes disease: Oral administration of glyoxal-bis(N(4)-methylthiosemicarbazonato)-copper(II) rescues the macular mouse.
Pediatric researchCerebrospinal Fluid-Directed rAAV9-rsATP7A Plus Subcutaneous Copper Histidinate Advance Survival and Outcomes in a Menkes Disease Mouse Model.
Molecular therapy. Methods & clinical developmentGrowing skull fracture at birth: a rare presentation of Menkes disease.
Archives of disease in childhoodNeuroimaging findings in Menkes disease: a rare neurodegenerative disorder.
BMJ case reportsVacuolization in Myeloid and Erythroid Precursors in a Child with Menkes Disease.
Turkish journal of haematology : official journal of Turkish Society of HaematologyNeuroimaging in Menkes Disease.
Journal of pediatric neurosciencesInteraction between the AAA ATPase p97/VCP and a concealed UBX domain in the copper transporter ATP7A is associated with motor neuron degeneration.
The Journal of biological chemistryMultimodal LA-ICP-MS and nanoSIMS imaging enables copper mapping within photoreceptor megamitochondria in a zebrafish model of Menkes disease.
Metallomics : integrated biometal scienceSpontaneous retroperitoneal hemorrhage in Menkes disease: A rare case report.
MedicineRare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant Pedigrees.
Cell systems[Recent Trends of Trace Element Studies in Clinical Medicine in Japan].
Nihon eiseigaku zasshi. Japanese journal of hygieneDisorders of metal metabolism.
Translational science of rare diseasesWilson disease and related copper disorders.
Handbook of clinical neurologyThe Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders.
Molecular pharmaceuticsTuning the Color Palette of Fluorescent Copper Sensors through Systematic Heteroatom Substitution at Rhodol Cores.
ACS chemical biologyMenkes disease: A rare disorder.
JPMA. The Journal of the Pakistan Medical AssociationA novel nonsense ATP7A pathogenic variant in a family exhibiting a variable occipital horn syndrome phenotype.
Molecular genetics and metabolism reportsHow to use tests for disorders of copper metabolism.
Archives of disease in childhood. Education and practice editionManagement of hyperplastic gastric polyp following upper gastrointestinal bleeding in infant with Menkes' disease.
World journal of gastrointestinal endoscopyA 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatment.
Clinical geneticsEvidence for widespread, severe brain copper deficiency in Alzheimer's dementia.
Metallomics : integrated biometal scienceNeuroimaging Changes in Menkes Disease, Part 1.
AJNR. American journal of neuroradiologyNeuroimaging Changes in Menkes Disease, Part 2.
AJNR. American journal of neuroradiologyGene expression patterns in the progression of canine copper-associated chronic hepatitis.
PloS one13 novel putative mutations in ATP7A found in a cohort of 25 Italian families.
Metabolic brain disease[Analysis of clinical features and genetic mutations in a Chinese family affected with Menkes disease].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsIdentification of novel ATP7A mutations and prenatal diagnosis in Chinese patients with Menkes disease.
Metabolic brain diseaseCharacterization of ATP7A missense mutants suggests a correlation between intracellular trafficking and severity of Menkes disease.
Scientific reportsMenkes Disease Mimicking Child Abuse.
Pediatric dermatologyMenkes disease and response to copper histidine: An Indian case series.
Annals of Indian Academy of NeurologyThe role of insufficient copper in lipid synthesis and fatty-liver disease.
IUBMB lifeAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Doença Menkes.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Doença Menkes
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Zycubo (copper histidinate), the first treatment for pediatric Menkes disease.
- Research Progress on Copper Metabolism, Cuprotosis, and Their Regulatory Mechanism in Tumor Diagnosis and Treatment.
- Copper Homeostasis and Cuproptosis in Neurological Disorders.
- Patient Burden in the Treatment of Wilson Disease in the United States: An Analysis of Real-World Health Insurance Claims Data from the Komodo database.
- Whole genome sequencing from dried blood spots for newborn screening of Menkes disease and 36 other actionable inherited neurometabolic disorders.
- Menkes Disease: Another Example of Progress in the Development of Pharmaceuticals for Rare Childhood Diseases, But Much Still Remains to Be Done.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:565(Orphanet)
- OMIM OMIM:309400(OMIM)
- MONDO:0010651(MONDO)
- GARD:1521(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Artigo Wikipedia(Wikipedia)
- Q639203(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
